Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Anti-asthmatic Effects of Samjajihwang-tang in OVA-induced Mice

삼자지황탕(三子地黃湯)의 생쥐 모델에 대한 항천식 효과

  • Kim, Woon-Kil (Division of Respiratory System, Department of Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Park, Yang-Chun (Division of Respiratory System, Department of Internal Medicine, College of Oriental Medicine, Daejeon University)
  • 김운길 (대전대학교 한의과대학 폐계내과학교실) ;
  • 박양춘 (대전대학교 한의과대학 폐계내과학교실)
  • Published : 2009.04.25
Download PDF
⟨ Previous Next ⟩

Abstract

This study aimed to evaluate the anti-asthmatic effects of Samjajihwang-tang (SJT) using OVA-induced asthmatic mice model. Asthmatic mice model was conducted by repeated challenge of OVA using C57BL/6 mice. Each group was treated with distilled water, SJT (400 mg/kg and 200 mg/kg) extract or cyclosporin A (10 mg/kg) for the later 8 weeks, Penh (plethysmography and enhanced pause), immune cells subpopulation, eotaxin, IL-5, TNF-${\alpha}$, Anti-OVA-lgE in BALF (bronchoalveolar lavage), and lung tissue was analyzed, No cytotoxicity of SJT was shown on hFCs (human fibroblast cells). Administration of SJT significantly decreased Penh levels comparing to control group. SJT treatment significantly ameliorated the increase of total cells number and eosinophil including of immune cell subpopulation of $CD3^+/CD69^+$, $CCR3^+$, $B220^+/CD22^+$, $B220^+/CD45^+$, and $B220^+/lgE^+$ cells in BALF comparing to control group. Eotaxin, IL-5, TNF-${\alpha}$, and Anti-OVA-lgE level in BALF were significantly decreased by SJT treatment too. Histopathological finding verified the improvement of infiltration of inflammatory cells and collagen tissue in the SJT groups comparing to control group. These results strongly suggest that SJT would be a effective candidate for herbal-originated anti-asthmatic drug. However, this drug should be further studied for characterization of the accurate action and underlying mechanisms using variant disease model in the future.

Keywords

References

  1. Braman, S.S. The global burden of asthma. Chest 130(1 Suppl):4S-12S, 2006 https://doi.org/10.1378/chest.130.1_suppl.4S
  2. 건강보험심사평가원. 2006년 건강보험통계지표. http://www. hira.or.kr/cms/rg/rgc/pds_02/1186060_1278.html
  3. 전국한의과대학 폐계내과학교실. 東醫肺系內科學. 서울, 한문화사, pp 329-331, 2002
  4. 홍천수, 김규언. 기관지천식-병인 및 역학. 대한 천식 및 알레르기학회, 천식과 알레르기 질환, 서울, 군자출판사, pp 244-245, 2002
  5. Muro, S., Minshal, E.M., Hamid, Q.A. The pathology of chronic asthma. Clin Chest Med 21(2):225-244, 2002
  6. 錢乙. 小兒藥證直訣. 남경, 강소과학기술출판사, pp 5-6, 1983
  7. Ko, E., Rho, S., Cho, C., Choi, H., Ko, S., Lee, Y., Hong, M.C., Shin, M.K., Jung, S.G., Bae, H. So-Cheong-Ryong-Tang, traditional Korean medicine, suppresses Th2 lineage development. Biol Pharm Bull 27(5):739-743, 2004 https://doi.org/10.1248/bpb.27.739
  8. 유선웅, 박양춘. 생쥐의 B세포에서 anti-CD40과 rIL-4로 유도된 Cytokine 생산과 IgE, Histamine에 대한 冷哮丸의 효과. 대한한방내과학회지 25(2):245-257, 2004
  9. 염종훈, 정희재, 정승기, 이형구. 定喘湯과 定喘湯加減方이 알레르기 천식모델 흰쥐의 BALF내 면역세포 및 혈청 IgE에 미치는 영향. 대한한의학회지 24(1):169-180, 2003
  10. 조영민, 정희재, 정승기, 이형구. 加味淸金降火湯 및 加味六味地黃湯이 Allergy 천식 모델 흰쥐의 BALF내 면역세포 및 혈청 IgE에 미치는 영향. 대한한의학회지 24(3):1-10, 2003
  11. 한영주, 박양춘. 감초(Glycyrrhiza uralensis Fisch, GLU)가 천식모델 생쥐의 BALF내 면역세포 및 Cytokine에 미치는 영향. 대한한방내과학회지 25(3):408-417, 2004
  12. 정승기, 황우석, 이재성, 최준용, 정희재, 이형구. 加味貝母湯의 기관지천식환자의 중증도에 따른 임상효과. 대한한의학회지 24(3):155-164, 2003
  13. 정승기, 정희재, 이재성, 이건영, 정승연, 이형구, 최준용. 加味淸上補下湯엑기스제의 기관지천식환자의 중증도에 따른 임상효과. 대한한의학회지 25(2):110-118, 2004
  14. 최준용, 이재성, 정승연, 이건영, 이경기, 정희재, 이형구, 정승기. 虛實辨證과 加味淸上補下湯의 임상효과. 대한한방내과학회지 25(3):379-387, 2004
  15. Finotto, S., De Sanctis, G.T., Lehr, H.A., Herz, U., Buerke, M., Schipp, M., Bartsch, B., Atreya, R., Schmitt, E., Galle, P.R., Renz, H., Neurath, M.F. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med 193(11):1247-1260, 2001 https://doi.org/10.1084/jem.193.11.1247
  16. 전국임상병리교수협의회. 조직검사학. 서울, 고려의학, pp 111-126, 2006
  17. 정승기, 이형구. 효천의 원인 및 치법에 관한 연구. 대한한의학회지 7(1):60-67, 1986
  18. 국한의과대학 본초학교실. 本草學. 서울, 영림사, pp 162- 163, 295-296, 370-374, 441-453, 482-484, 589-593, 1991
  19. 두호경 편저. 東醫腎系內科學. 서울, 동양의학연구원, p 1434, 1993
  20. 조세형. 素虛後世處方學. 서울, 계축문화사, p 68, 1984
  21. Boot,h B.W., Newcomb, D.C., McKane, S.A., Crews, A.L., Adler, K.B., Bonner, J.C., Martin, L.D. Proliferation of the airway epithelium in asthma are inflammatory cells required? Chest, 123(3 Suppl):384-385, 2003 https://doi.org/10.1378/chest.123.3_suppl.384S
  22. Nomura, A., Uchida, Y., Sakamoto, T., Ishii, Y., Masuyama, K., Morishima, Y., Hirano, K., Sekizawa, K. Increases in collagen type I synthesis in asthma: the role of eosinophils and transforming growth factor-beta. Clin Exp Allergy 32(6):860-865, 2002 https://doi.org/10.1046/j.1365-2745.2002.01404.x
  23. Erin, E.M., Williams, T.J., Barnes, P.J., Hansel, T.T. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease. Curr Drug Targets Inflamm Allergy 1(2):201-214, 2002 https://doi.org/10.2174/1568010023344715
  24. Murdoch, C., Finn, A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95(10):3032-3043, 2000
  25. Ying, S., Meng, Q., Zeibecoglou, K., Robinson, D.S., Macfarlane, A., Humbert, M., Kay, A.B. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol 163(11):6321-6329, 1999
  26. 김태윤. 알레르기 염증반응에서 사이토카인과 케모카인. 대한 천식 및 알레르기학회, 천식과 알레르기 질환. 서울, 군자출판사, pp 55-58, 2002
  27. Gangur, V., Birmingham, N.P., Thanesvorakul, S., Joseph, S. CCR3 and CXCR3 as drug targets for allergy. principles and potential. Curr Drug Targets Inflamm Allergy 2(1):53-62, 2004 https://doi.org/10.2174/1568010033344453
  28. Nakamura, T., Kloetzer, W.S., Brams, P., Hariharan, K., Chamat, S., Cao, X., LaBarre, M.J., Chinn, P.C., Morena, R.A., Shestowsky, W.S., Li, Y.P., Chen, A., Reff, M.E. In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain. Int J Immunopharmacol 22(2):131-141, 2000 https://doi.org/10.1016/S0192-0561(99)00068-5
  29. 조상헌. IgE 항체 생성과 조절. 알레르기 13: 460-464, 1993
  30. Forssmann, U., Uguccioni, M., Loetscher, P., Dahinden, C.A., Langen, H., Thelen, M., Baggiolini, M. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 185(12):2171-2176, 1997 https://doi.org/10.1084/jem.185.12.2171
  31. Hamelmann, E., Gelfand, E.W. IL-5-induced airway eosinophilia-the key to asthma. Immunol Rev 179: 182-191, 2001 https://doi.org/10.1034/j.1600-065X.2001.790118.x
  32. Greenfeder, S., Umland, S.P., Cuss, F.M., Chapman, R.W., Egan, R.W. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res 2(2):71-79, 2001 https://doi.org/10.1186/rr41
  33. Punnonen, J., Aversa, G., Cocks, B.G., de Vies, J.E. Role of interleukin-4 and interleukin-13 in synthesis of IgE and expression of CD23 by human B cells. Allergy 49(8):576-586, 1994 https://doi.org/10.1111/j.1398-9995.1994.tb00122.x
  34. Steinke, J.W., Borish, L. Th2 cytokines and asthma. Interleukin-4. its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res 2(2):66-70, 2001 https://doi.org/10.1186/rr40
  35. Thomas, P.S. Tumour necrosis factor-alpha. the role of this multifunctional cytokine in asthma. Immunol Cell Biol 79(2):132-140, 2001 https://doi.org/10.1046/j.1440-1711.2001.00980.x
  36. Oettgen, H.C., Geha, R.S. IgE in asthma and atopy. cellular and molecular connections. J Clin Invest 104(7):829-835, 1999 https://doi.org/10.1172/JCI8205
  37. 최인선. 천식의 병리. 대한 천식 및 알레르기학회, 천식과 알레르기 질환. 서울, 군자출판사, pp 257-264, 2002
  38. Elias, J.A., Zhu, Z., Chupp, G., Homer, R.J. Airway remodeling in asthma. J Clin Invest 104(8):1001-1006, 1999 https://doi.org/10.1172/JCI8124
  39. 김관형. 기도 개형. 결핵 및 호흡기질환 60(6):608-624, 2006